# | Organization | Presenter | Title |
1 | IMA | Guia Bertuzzi | The potential of Croma continuous coater |
2 | Glatt | Ed Godek | Direct Tableting a mixture of a powder matrix and API loaded pellets (MUPS) |
3 | MIT | Alexis B. Dubs | Continuous Manufacturing Testbed Development and Data Release for a Monoclonal Antibody Production Process |
4 | Procegence | Nima Yazdanpanah | Model-based Product and Process Development for Accelerated and Efficient Scale-up and Tech-transfer |
5 | Lilly | Wyatt J Roth | Advancements in the Application of Continuous Manufacturing at Eli Lilly and Company |
6 | Sanofi | Yuanli Song | Manufacturability Assessment for Adeno-Associated Virus (AAV) CMC Development. |
7 | Sanofi | Kevin Brower | End-to-End Integrated Continuous Biomanufacturing at Sanofi: Case Studies in Advancing Advanced Manufacturing |
8 | ArrantaBio | Jing Zhu | A Complete, End-to-End CDMO Solution for Plasmid, RNA, LNP Formulation and Injectable Sterile Drug Product |
9 | Continuus | Bhakti Halkude | Continuous Manufacturing of OSDs with Extrusion Injection Molding- a single unit operation continuous tablet manufacturing technology |
10 | Continuus | Wei Wu | Implementation of the integrated continuous manufacturing (ICM) technology for drug substance production |
11 | Rutgers University | Carlos Ortega-Zuniga | A Real-Time Quality Control Toolbox for Predicting the Dissolution Profile of Tablets from a Continuous Pharmaceutical Manufacturing Pilot-Plant Using a Non-Destructive NIR Spectroscopy Method |
12 | Rutgers University | Zankrut Vyas | Enhancing the Oral Bioavailability of Poorly Soluble Drug through Twin-Screw Melt Coating and Granulation |
13 | MIT/Takeda | Thomas Toupy | Integrated end-to-end continuous flow manufacturing platform towards advanced API intermediate. |
14 | MIT | Francesco Destro | Mechanistic Modeling to Enhance Continuous Manufacturing of Recombinant Adeno-Associated Virus with Insect Cells |
15 | CMAC | Massimo Bresciani | CMAC Pillar 4: Exemplary Translation to Industry. Driving the impact of research |
16 | CMAC | Cameron Brown | Towards a Crystallisation Classification System for Pharmaceutical Ingredients |
17 | CMAC | Kenny Smith | Continuous Crystallisation & Advanced Characterisation – Case Studies |
18 | CMAC | Catriona Clark | Digital Design and Manufacture of Amorphous Materials |
19 | CMAC | Chantal Mustoe | Quality by Digital Design (QbDD): An Integrated Approach to Digital Transformation of CMC and Product Quality |
20 | CMAC | Jonathan Moores | Digital Medicines Manufacturing (DM2) Centre |
21 | Sanofi | Ying Liu | Development and Scale-up of Adeno-Associated Virus (AAV) Transient Transfection Manufacturing Process with Improved Productivity |
22 | Parc/Xerox | Nazly Pirmoradi | Hot-melt Inkjet 3D printing of Lipid-based Solid Oral Dosage Forms |
23 | FDA | Adil Mohammad | Development of Continuous Synthesis and Crystallization Reactor System for Carbamazepine using Integrated Process Analytical Technologies |
24 | FDA | Thomas O’Connor | Applications of Residence Time Distribution Modeling in Continuous Pharmaceutical Manufacturing |